result line slight om/ep upsid core outlook
trim slightli industri short cycl busi
measur analyt solut segment overal organ outlook
vs prior process organ expect upstream
soft well flagged/plan allow focu cash margin pt op
flat y-o-i om bp within soft emerg broadli
across industri busi rel narrow within sweep
rapidli june bounc back juli project hsd vs msd
continu track solidli msd organ trend-line
adj ep rose y-o-i beat consensu
guidanc adj sale grew y-o-i organ
acquisit fx match estim segment om
bp top estim adj op rose vs forecast
roper rais adjust ep guidanc
prior consensu organ growth prior adj
ep guidanc compar prior
consensu gatan add regulatori stop sale wide interest note
elsewher tax rate add vs prior partli off-set short
end debt/ebitda net indic pipelin
actionable/attract deal remain steadi rich long term compani
target steadi state leverag room short term right
deal would follow rapid debt reduct gross margin rose
bp y-o-i regist four straight quarter
model cfo/ani fcf/ani consist long-
term expect fcf-per-share reflect y-o-i short-
term model item includ moder y-o-i om pressur nss foundri
impact/amort mix/growth off-set foundri mix/
align time also neutral short cycl industri soft hit
quickli late
rais ep
pt remain base current ep pt reflect
yield vs current market cap assum steadi
pace acquisit would approach pf yield compar current
year price histori
roper oper busi design
develop softwar engin
product solut varieti
food energi water educ
analyst certif import disclosur see disclosur
robust gener solid convers deal pipelin
remain attract long-term opportun steadi
persist organ growth serv market high-
qualiti portfolio busi rop strong posit
solid balanc sheet cash flow outlook allow
compound flexibl capit opportunist acquisit
upsid oper leverag softwar acquisit growth
larger deal past year look favor vs deal case
acceler perform deal close cyclic exposur
process cyclic snap-back later cycl exposur
inabl execut deal flow expect
period close materi acquisit
pt target current ep pt reflect yield vs current market cap
assum steadi pace acquisit would approach pf yield compar current yield impli upsid
potenti includ dividend yield
risk achiev price target medic growth underperform toll busi lumpi pend slower deal flow
record deal activ notwithstand pay debt
exhibit segment result varianc opco estim
report adjust ep vs year ago compar
consensu guidanc adjust revenu grew year-over-
year organ acq fx match estim adjust segment margin
expand bp y-o-i beat estim adjust gross margin widen bp y-o-i
guidanc manag rais ep guidanc vs prior
consensu organ outlook prior third-quart adjust ep
guidanc compar prior consensu guidanc add gatan
back expect tax rate vs prior add
flow/bal sheet end cash net debt/capit vs
end gross leverag net leverag vs year-end
vs last year cfo/ani fcf/ani
applic softwar sale
revenu increas y-o-i organ acquisit fx vs estim
ader doubl digit adjust om contract bp vs estim
reflect characterist lumpi time margin-rich-licens win deltek flat y-o-i
expect msd
manag expect organ growth segment stronger deltek
comparison normal consid project time new win
network softwar system sale
revenu rose y-o-i organ acquisit match estim itrad rose
high-singl digit freight-match dd strong share/market dynam featur mha
adjust om expand bp vs estim
measur analyt solut sale
revenu decreas y-o-i organ divestitur fx vs estim
driven imag sale impact organ reflect msd declin short cycl industri off-set
strong om expand bp vs estim
manag expect organ growth medic products/neptun mid-singl
digit short cycl industri busi expect high-singl digit expect
gatan add modest organ declin follow termin divestitur plan
process technolog sale
revenu fell y-o-i organ fx round vs estim upstream
 declin om expand bp y-o-i vs estim
manag expect organ easier y-o-i comparison vs
annual sale profit segment
earn continu oper
loss discontinu operations/oth
compani report oppenheim co inc estim
quarterli sale profit segment
earn continu oper
loss disc ops/oth adj
compani report oppenheim co inc estim
analysi oper
segment revenu
total segment revenu
segment profit
total segment profit
compani report oppenheim co inc estim
year end decemb million
good sold
earn continu oper
loss discontinu operations/oth
compani report oppenheim co inc estim
sale
earn continu oper
loss disc ops/oth adj
year end decemb million
current portion long term debt
average day inventori day hand
compani report oppenheim co inc estim
consolid statement flow
year end decemb million
depreci pp
goodwil transit impair net tax
dispos busi
net chang work capit
busi acquisit net acquir
proce note payabl lt debt
princip pmt note payabl lt debt
issuanc common stock
increas dec
equival -b
equival -e
compani report oppenheim co inc estim
